共 52 条
[41]
Shah Manisha H, 2021, J Natl Compr Canc Netw, V19, P839, DOI 10.6004/jnccn.2021.0032
[44]
177Lu-Dotatate plus long-acting octreotide versus high-dose long-acting octreotide in patients with midgut neuroendocrine tumours (NETTER-1): final overall survival and long-term safety results from an open-label, randomised, controlled, phase 3 trial
[J].
LANCET ONCOLOGY,
2021, 22 (12)
:1752-1763
[45]
Taal B G, 2004, Neuroendocrinology, V80 Suppl 1, P3, DOI 10.1159/000080731